Suma Krishnan, President, R&D at Krystal Biotech, sold KRYS on Sep 4, 2026
Data as of Oct 16
- Traded
- Sep 4, 2026
- Disclosed
- Sep 4, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KRYS since disclosure
−11.6%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund
Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$1.1Mdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$713Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$205Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$1.2Mdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$1.4Mdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$484Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$302Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$146Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$449Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$184Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$836Kdisclosed Sep 4 · filed the same day
- ▼ SELLSuma Krishnan President, R&DKRYS Krystal Biotech, Inc.$1.2Mdisclosed Sep 4 · filed the same day